Pay in 4 interest-free payments of $6.72 Learn more
Ships within 48 hours · Estimated delivery Nov 9 - Nov 14
Tirzepatide was approved in 2022 as Mounjaro for diabetes, and in 2024 as Zepbound for obesity, with exclusivity running until May 2027
For patients who have difficulty absorbing B12 through the digestive tractsuch as those with pernicious anemia, gastrointestinal disorders (like Crohns disease or celiac disease), a history of gastric bypass surgery, or those with severe B12 deficiencyour providers often recommend intramuscular B12 injections
Kretzschmar, M., & Klinger, W
The following schedule applies across all Child-Pugh classes, with frequency adjusted upward for higher severity
US$ 23.33
US$ 27.14
US$ 20.55
US$ 21.93
US$ 25.21
US$ 24.09
US$ 24.30
US$ 23.50
US$ 22.49
